Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea
· Delayed Price · Currency is KRW 244,000
-5,500 (-2.20%)
Mar 11, 2025, 9:00 AM KST
Hanmi Pharm. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | - | 146,231 | 82,792 | 67,025 | 11,959 | Upgrade
|
| Depreciation & Amortization | - | 98,454 | 96,842 | 89,086 | 61,339 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -1,769 | -451.65 | 1,062 | 313.72 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 9,153 | 3,794 | 535.2 | -470.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -2,630 | -47.09 | - | 4,514 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -1,258 | 8,537 | 4.02 | 0.02 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 1,277 | 723.06 | 5,118 | 374.19 | Upgrade
|
| Other Operating Activities | - | 24,476 | 43,766 | 92,609 | 31,431 | Upgrade
|
| Change in Accounts Receivable | - | -3,217 | 37,286 | -76,613 | 32,478 | Upgrade
|
| Change in Inventory | - | -16,903 | -14,365 | 18,916 | 4,885 | Upgrade
|
| Change in Accounts Payable | - | 5,574 | -2,736 | 9,794 | -5,308 | Upgrade
|
| Change in Other Net Operating Assets | - | -42,852 | -93,870 | -5,613 | 10,020 | Upgrade
|
| Operating Cash Flow | - | 216,538 | 162,269 | 201,923 | 151,535 | Upgrade
|
| Operating Cash Flow Growth | - | 33.44% | -19.64% | 33.25% | 1117.48% | Upgrade
|
| Capital Expenditures | - | -27,352 | -30,378 | -19,949 | -41,815 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 2,600 | 1,397 | 86.37 | 80.8 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -16,156 | -20,273 | -14,199 | -15,935 | Upgrade
|
| Investment in Securities | - | -138,865 | -118,609 | -6,953 | 13,994 | Upgrade
|
| Other Investing Activities | - | -3,699 | -13,545 | -2,375 | -1,491 | Upgrade
|
| Investing Cash Flow | - | -183,472 | -181,408 | -43,389 | -45,166 | Upgrade
|
| Short-Term Debt Issued | - | 134,650 | 230,000 | 102,700 | 159,200 | Upgrade
|
| Long-Term Debt Issued | - | - | 7,000 | 30,000 | 21,800 | Upgrade
|
| Total Debt Issued | - | 134,650 | 237,000 | 132,700 | 181,000 | Upgrade
|
| Short-Term Debt Repaid | - | -167,650 | -116,800 | -198,800 | -184,200 | Upgrade
|
| Long-Term Debt Repaid | - | -72,720 | -147,240 | -36,476 | -50,766 | Upgrade
|
| Total Debt Repaid | - | -240,370 | -264,040 | -235,276 | -234,966 | Upgrade
|
| Net Debt Issued (Repaid) | - | -105,720 | -27,040 | -102,576 | -53,966 | Upgrade
|
| Repurchase of Common Stock | - | -3,071 | -3,834 | -4,874 | -3,083 | Upgrade
|
| Dividends Paid | - | -17,996 | -5,992 | -5,881 | -8,140 | Upgrade
|
| Other Financing Activities | - | -0 | - | - | - | Upgrade
|
| Financing Cash Flow | - | -126,787 | -36,867 | -113,331 | -65,190 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1,373 | -5,890 | 17,864 | -1,134 | Upgrade
|
| Net Cash Flow | - | -92,348 | -61,896 | 63,067 | 40,044 | Upgrade
|
| Free Cash Flow | - | 189,186 | 131,890 | 181,974 | 109,719 | Upgrade
|
| Free Cash Flow Growth | - | 43.44% | -27.52% | 65.85% | - | Upgrade
|
| Free Cash Flow Margin | - | 12.69% | 9.91% | 15.12% | 10.20% | Upgrade
|
| Free Cash Flow Per Share | - | 14906.67 | 10382.37 | 14307.73 | 8617.07 | Upgrade
|
| Cash Interest Paid | - | 27,846 | 19,498 | 18,315 | 23,596 | Upgrade
|
| Cash Income Tax Paid | - | 31,432 | 29,632 | 6,599 | 14,693 | Upgrade
|
| Levered Free Cash Flow | - | 156,408 | 193,044 | 159,618 | 64,927 | Upgrade
|
| Unlevered Free Cash Flow | - | 174,226 | 207,199 | 169,979 | 80,469 | Upgrade
|
| Change in Net Working Capital | -188,753 | 21,273 | -64,823 | -36,655 | -46,269 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.